Study: Barendse 2001 |
Methods | RCT; “randomized to two treatment groups by computer program” |
Participants | 28 patients, aged 30–65 years, with a history of chronic LBP >12 months referred to a pain management centre. Only patients with a positive response to analgesic discography (>50% temporary reduction in pain over 30 min) were included. Exclusion criteria were multilevel discogenic pain, spinal stenosis, spondylolisthesis, coagulation disturbances, pregnancy, high VAS, diabetes mellitus, and positive diagnostic block of L3, L4 or L5 zygapophysial joints |
Interventions | Injection treatment (I): percutaneous intra-discal radiofrequency thermocoagulation (radiofrequency probe inserted via cannula into disc using tunnel vision fluoroscopy), creating a 90-s 70°C lesion (n = 13) Reference treatment (R): sham radiofrequency thermocoagulation (treated in an identical way, but no radiofrequency current was applied) (n = 15) |
Outcomes | No significant differences were found for any of the primary or secondary outcomes after 8 weeks post-treatment. Change in VAS was −0.61 in (I) and −1.14 in (R); while change in Oswestry scale was −2.62 in (I) and −4.93 in (R) |
Notes | No complications during or after the procedures were reported. Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance +; drop outs −; timing of outcomes +; intention-to-treat +. Total score = 9 |
Study: Carette 1991 |
Methods | RCT; “generated from a table of random numbers” |
Participants | 101 patients, aged 18–65 years, with chronic LBP and a positive response to lumbar facet joint anaesthetic block. Exclusion criteria included specific LBP, previous injections into the facet joints, previous low-back surgery, pregnancy, known allergy to local anaesthetic and the presence of a blood coagulation disorder Four patients were later excluded from the analysis. |
Interventions | Injection treatment (I): lumbar facet joint injection of corticosteroid (1 ml methylprednisolone acetate mixed with 1 ml isotonic saline) (n = 49) Reference treatment (R): sham lumbar facet joint injection (2 ml isotonic saline) (n = 48) |
Outcomes | One to 3 months post-treatment, the two groups did not differ clinically or statistically in any of the outcome measures. By 6 months post-treatment, patients treated with (I) reported significantly better VAS (mean difference −1.0, 95% CI −2.0 to −0.1) and sickness impact profile-physical dimension scores (mean difference −3.0, 95% CI −5.5 to −0.5) compared with (R) |
Notes | No adverse events were reported, other than transient local pain at the injection sites. Methodological quality: randomization +; treatment allocation ?; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 8 |
Study: Dashfield 2005 |
Methods | RCT; “allocated randomly” |
Participants | 60 patients, aged 18 years or more, with sciatica (defined as pain in the distribution of a lumbar nerve root, ± neurosensory and motor deficits) for a minimum of 6 months, but not for longer than 18 months. Patients with previous spinal surgery, coagulopathy, progressive motor neurone disorders, or peripheral vascular disease were excluded |
Interventions | Injection treatment (I): caudal epidural corticosteroid injection (10 ml lidocaine 1% with 40 mg triamcinolone) injected into the epidural space (n = 33) Injection treatment (I2): lumbar epiduroscopy (painful nerve root identified and instilled with 10 ml lidocaine 1% with triamcinolone 40 mg) (n = 27) |
Outcomes | No significant differences were found between the groups after 6 weeks, 3 months and 6 months post-treatment for any of the measures. For the (I) group, there were more significant differences between pre-treatment and post-treatment outcome measures compared with the (I2) group |
Notes | Non-persistent post-procedure low-back discomfort occurred in all (I2) patients, and in fewer (I) patients Methodological quality: randomization ?; treatment allocation +; baseline similarity −; patients blinded +; care providers blinded −; outcomes blinded +; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat ?. Total score = 6 |
Study: Ercelen 2003 |
Methods | RCT; “patients were randomized into two treatment groups by computer” |
Participants | 39 patients with chronic LBP who had been receiving conservative treatment for at least 2 years. Patients with spinal stenosis, instability, spondylolisthesis, diabetes mellitus, tumour infiltration, coagulation disorders, clinical radiculopathy, other neurologic abnormalities or systemic inflammatory diseases were excluded from the study. Only patients with a positive provocative discography at L4–L5, L5–S1, or both locations were randomized Two patients were excluded from the analysis (one with discitis, one lost to follow up) |
Interventions | Injection treatment (I1): percutaneous intradiscal radiofrequency thermocoagulation (radiofrequency probe inserted via cannula into disc using fluoroscopy) at 80°C. Lesioning was performed for 120 s (n = 19) Injection treatment (I2): percutaneous intradiscal radiofrequency thermocoagulation, identical procedure to (I1) but lesioning was performed at 80°C for 360 s (n = 18) |
Outcomes | No significant differences were observed between groups at any of the follow-up time points (post-treatment, 1 and 2 weeks, 1, 3, and 6 months). Post-treatment to 1 month scores on pain VAS and Oswestry disability scale decreased significantly compared with pre-treatment scores (P < 0.05). There were no statistical differences between the final (6 month) and the pre-treatment VAS and ODS values in both groups |
Notes | Adverse events were not reported Methodological quality: randomization +; treatment allocation −; baseline similarity +; patients blinded ?; care providers blinded −; outcomes blinded ?; co-interventions ?; compliance ?; drop outs +; timing of outcomes +; intention-to-treat ?. Total score = 4 |
Study: Foster 2001 |
Methods | RCT; “randomly assigned by drawing a card from a deck of shuffled cards” |
Participants | 31 patients aged >18 years with chronic LBP greater on one side than the other. Exclusion criteria were LBP for <6 months, presence of a systemic inflammatory disorder, acute pathology on MRI, known allergy or sensitivity to botulinum toxin, pregnancy, disorders of neuromuscular transmission and anaesthetic or corticosteroid injections to the lumbar spine within 12 weeks of enrolment |
Interventions | Injection treatment (I): intramuscular injections of botulinum toxin A at 5 lumbosacral sites, with each site receiving 40 units (n = 15) Reference treatment (R): intramuscular injections of saline to at 5 lumbosacral sites, with each site receiving 40 units (n = 16) |
Outcomes | At 3 weeks, the degree of pain relief exceeded 50% (VAS score) in 11 of 15 patients (73.3%) in the (I) group compared with four of 16 (25%) in the (R) group (P < 0.012). The difference between these groups was 48% (95% CI 11.7–80.1). At 8 weeks, 9 of 15 patients (60%) in the (I) group and 2 of 16 (12.5%) in the (R) group reported pain relief exceeding 50% (P < 0.009), a difference of 47.5% (95% CI 10.5–79.1). For the Oswestry, 10 of 15 patients (66.7%) in the (I) group and 3 of 14 (18.8%) in the (R) group demonstrated improvement at 8 weeks (P < 0.011). The difference between groups was 47.9% (95% CI 10.9–79.6) |
Notes | Injections were well tolerated by all patients and none had side effects Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded +; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 9 |
Study: Freeman 2005 |
Methods | RCT; “randomization schedule” |
Participants | 57 patients with chronic LBP and evidence of degenerative disc disease on MRI. All subjects had one- or two-level symptomatic disc degeneration as determined by provocative lumbar discography. Exclusion criteria included the presence of a large contained or sequestered herniation, spinal stenosis, previous back surgery, spondylolisthesis, psychological disorders, and pregnancy Two subjects violated protocol and were not included in the analysis |
Interventions | Injection treatment (I): intradiscal electrothermal therapy (IDET) at 90°C for 4 min, followed by a rehabilitation program (n = 38) Reference treatment (R): sham IDET, same procedure as (I) without connection to the generator, followed by a rehabilitation program (n = 19) |
Outcomes | 6 months post-treatment, there were no significant differences between groups on any of the primary or secondary outcome measures. Mean difference (95% CI) between groups on the low-back outcome score was −1.71 (−3.82 to 0.41) and on Oswestry was −2.16 (−8.37 to 4.86) in favour of (I) |
Notes | There were no serious adverse events in either arm of the study Methodological quality: randomization ?; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 8 |
Study: Fuchs 2005 |
Methods | RCT; block randomization generated by computer |
Participants | 60 patients with chronic LBP with radiologic confirmation of facet joint osteoarthritis. Patients with a history of hypersensitivity or contraindication to the test products, contraindication to intra-articular treatment, a current regimen of anticoagulants or radicular pain were excluded from the study |
Interventions | Injection treatment (I): lumbar facet joint sodium hyaluronate injections (10 mg sodium hyaluronate in 1 ml buffer solution) bilaterally, under CT guidance at weekly intervals, for 3 weeks (n = 30) Injection treatment (I2): lumbar facet joint corticosteroid injection (10 mg triamcinolone acetonide in 1 ml crystalline suspension) bilaterally, under CT guidance at weekly intervals, for 3 weeks (n = 30) |
Outcomes | No statistically significant differences between the groups in any outcomes were reported post-treatment, after 3 and 6 months. Pain VAS in the (I) group decreased from 69.2 ± 14.2 to 38.0 ± 26.5 mm by 3 months post-treatment. In the (I2) group the pain intensity decreased from 68.7 ± 11.5 to 33.4 ± 20.7 mm |
Notes | No adverse effects were reported after administration of both therapies Methodological quality: randomization +; treatment allocation ?; baseline similarity +; patients blinded −; care providers blinded −; outcomes blinded ?; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 5 |
Study: Gallagher 1994 |
Methods | RCT; randomisation method not stated |
Participants | 41 patients, aged 25–55 years, with chronic LBP who fulfilled criteria for facet joint pain (including tenderness on palpation; pain on extension or rotation; pain exacerbated by exercise, sitting, and standing; and radiological evidence of facet joint degeneration). Subjects had a positive response to local anaesthetic injection into and around the painful joint. Exclusion criteria included previous back surgery, signs of nerve root compression, major mental illness, pending compensation claims and general ill health |
Interventions | Injection treatment (I): radiofrequency denervation of lumbar facet joints at 80°C for 90 s (n = 24) Reference treatment (R): sham radiofrequency denervation with identical procedure except for the radiofrequency lesion (n = 27) |
Outcomes | Analyses were split to allow comparisons between those with a good (n = 30) or equivocal (n = 11) response to facet joint block. Subjects with a good response in the (I) group had significantly lower mean (SE) VAS (34 (6.9) vs. 60 (9.8)) and McGill pain scores (9 (2.3) vs. 16 (2.8)) 1 month post-treatment, compared with the (R) group. 6 months post-treatment VAS scores were significantly low in the (I) compared with (R). In subjects with an equivocal response to facet joint block, no significant differences were found between groups at any time-point |
Notes | Adverse events were not reported Methodological quality: randomization ?; treatment allocation ?; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded +; co-interventions ?; compliance ?; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 6 |
Study: Geurts 2003 |
Methods | RCT; “randomly allocated” |
Participants | 83 patients, aged 18 years and more, with chronic LBP and a predominance of leg pain who responded positively to lumbar nerve blocks. Exclusion criteria were: previous radiofrequency treatment; indications for surgery (great pain, rapid progressive paresis, cauda equina syndrome); pregnancy; coagulation disorders; malignant disease; allergy to radiopaque contrast or local anaesthetics; and presence of neuropathic sensory or motor deficit, a non-segmental pattern of irradiating leg pain, or both Three patients required surgery post-treatment and were excluded from the analysis |
Interventions | Injection treatment (I): radiofrequency lesioning of dorsal root ganglion at 67°C for 90 s (n = 44) Reference treatment (R): sham radiofrequency lesioning of dorsal root ganglion, identical procedure as (I) without the application of radiofrequency current (n = 36) |
Outcomes | Three months post-treatment, 16% of (I) were assessed to have had successful treatment compared with 25% in (R) group, based on a composite outcome measure (difference −9.1% [95% CI −33.0 to 12.0], P = 0.43). No significant differences between groups were reported for mean change scores (SD) on back pain VAS (I) −0.6 (2.2) versus (R) −1.1 (2.4); change in daily activities (I) −0.5 (3.9) versus (R) −0.4 (3.4); change in analgesics use (I) 0.1 (1.4) versus (R) −0.2 (0.9); global subjective efficacy rating of benefit (I) 21% versus (R) 17%; or on any SF-36 subscales |
Notes | 41 patients had at least one previous low-back surgery Adverse events did not differ between treatments, and no serious complications or side effects arose in either group Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 10 |
Study: Kvarstein 2009 |
Methods | RCT; “randomized” |
Participants | 20 patients aged 20–65 years, with unremitting low-back pain for 6 months. All patients with signs of disc degeneration (MRI) or posterior annular tear (CT) underwent a three-level (L3/L4, L4/L5 and L5/S1) pressure-controlled provocation discography. Patients were eligible if the discography reproduced typical (‘‘concordant”) and intensive low-back pain (>7/10) at only one of the three levels. All eligible patients had pain >5/10 which was exacerbated by sitting and relieved by laying. Exclusion criteria included: positive medial branch blocks, acute infection, history of drug abuse, psychological disturbance, previous spine surgery, abnormal neurological examination, structural deformities or canal stenosis, pregnancy and disc herniations >4 mm |
Interventions | Injection treatment (I): percutaneous intradiscal radiofrequency thermocoagulation (PIRFT) at a single level for 10 min (starting at 50°C, increasing by 5°C every 2 min, and ending with 4 min at 65°C) (n = 10) Reference treatment (R): sham percutaneous intradiscal radiofrequency thermocoagulation (PIRFT), same procedure as above but the annulus was not exposed to RF heating (n = 10) |
Outcomes | After 6 months, there were no significant differences between (I) and (R) on pain intensity. Mean (SD) pain intensity at baseline, 6 and 12 months: (I) 5.4 (2.1), 4.4 (2.7), 4.0 (3.0) versus (R) 6.5 (2.2), 6.5 (2.0), 4.9 (2.7), respectively. No significant differences were observed between groups on any of the secondary outcome measures |
Notes | Any serious adverse effects attributable to the treatment were not reported Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded +; co-interventions −; compliance −; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 8 |
Study: Leclaire 2001 |
Methods | RCT; “randomization was performed in blocks of four” |
Participants | 70 patients, aged 18–65 years, with chronic LBP and positive lumbar facet joint block. Exclusion criteria included allergy to local anaesthetic, blood coagulation disorder, cardiac pacemaker, sciatic pain with neurological deficit, specific low-back pain and previous low-back surgery |
Interventions | Injection treatment (I): radiofrequency facet joint denervation under fluoroscopic guidance, 80°C for 90 s at a minimum of two levels (n = 36) Reference treatment (R): sham radiofrequency denervation, same procedure as (I), without radiofrequency lesion (n = 34) |
Outcomes | After 4 weeks, mean (SD) Roland–Morris scores improved by 8.4 (17.4) in the (I) group and by 2.2 (14.7) in (R), showing a mean difference (95% CI) of 6.2 (−1.3 to 13.8). There was no significant treatment effect after 12 weeks. No significant differences were found at any time point for pain VAS, Oswestry score, or the secondary outcomes |
Notes | No complications after the intervention was reported by patients Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded +; co-interventions +; compliance +; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 10 |
Study: Lierz 2004 |
Methods | RCT; randomization performed by computer |
Participants | 40 patients, aged 20–70 years, with chronic LBP. Exclusion criteria included presence of a motor deficit, recent change of analgesics, pulmonary hypertension, pulmonary artery stenosis, aortic stenosis, mitral stenosis, AV-block grade III, extreme hypovolaemia, coagulation disorders, pregnancy or sepsis/infection |
Interventions | Injection treatment (I): lumbar epidural block (10 ml ropivacaine 0.2%) (n = 20) Injection treatment (I2): lumbar epidural block (10 ml bupivacaine 1.125%) (n = 20) Eight single shot epidural blocks at an interval of 2 or 3 days. Active physiotherapy was performed immediately after each session in both groups |
Outcomes | There was no significant difference between groups in analgesia post-treatment. Mean (SD) pain intensity in (I) decreased from 7.0 (1.6) to 4.0 and from 7.1 (1.6) in (I2) to 4.2. No significant differences between groups were reported in haemodynamic variables |
Notes | There were three cases of short episodes of headache, two in the (I) group and one in the (I2) group. Methodological quality: randomization +; treatment allocation ?; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded ?; co-interventions +; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 8 |
Study: Lilius 1989 |
Methods | RCT; randomisation method not stated |
Participants | 109 patients aged 19–64 years with chronic LBP |
Interventions | Injection treatment (I): lumbar facet joint injection of corticosteroid and local anaesthetic [6 ml (30 mg) bupivacaine hydrochloride mixed with 2 ml (80 mg) methylprednisolone acetate] (n = 28) Injection treatment (I2): the same mixture, injected peri-capsularly around the lumbar facet joint (n = 39) Reference treatment (R): sham lumbar facet joint injection (8 ml of physiological saline) (n = 42) |
Outcomes | No significant differences between groups was seen post-treatment, after 2 weeks, or after 6 weeks in work status, pain intensity, or physical range of motion measurements. Data in graphs |
Notes | Twenty-seven patients had a history of previous vertebral disc surgery Few side effects were reported and their occurrence did not differ between groups Methodological quality: randomization ?; treatment allocation −; baseline similarity ?; patients blinded −; care providers blinded −; outcomes blinded −; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 3 |
Study: Manchikanti 2001 |
Methods | RCT; randomization procedure not described |
Participants | 73 patients with LBP with or without lower extremity pain for more than 6 months who did not exhibit neurological deficits and who responded positively to lidocaine blocks |
Interventions | Injection treatment (I): lumbar facet joint injection with local anaesthetic and Sarapin (0.5% lidocaine or 0.25% bupivacaine mixed with equal volumes of Sarapin) (n = 32) Injection treatment (I2): lumbar facet joint injection with a mixture of local anaesthetic, Sarapin, and corticosteroid (0.5% lidocaine or 0.25% bupivacaine mixed with equal volumes of Sarapin and 1 mg of methyl prednisolone/ml of the mixture) (n = 41) |
Outcomes | Results showed that patients underwent multiple procedures over a period of 2½ years. Post-treatment, no significant differences were reported between the groups in pain relief, overall health status, physical, functional or psychological status. Average pain scores (mean ± SEM) decreased from 7.6 ± 0.13 to 3.5 ± 0.26 in (I) and from 7.7 ± 0.12 to 3.3 ± 0.15 in (I2) |
Notes | 17 patients had previous lumbar laminectomy No complications were reported in any of the patients Methodological quality: randomization ?; treatment allocation −; baseline similarity +; patients blinded −; care providers blinded −; outcomes blinded ?; co-interventions −; compliance +; drop outs +; timing of outcomes −; intention-to-treat −. Total score = 3 |
Study: Manchikanti 2008 |
Methods | RCT; “computer-generated random allocation sequence” |
Participants | 120 patients aged over 18 years with chronic non-specific LBP and a diagnosis of lumbar facet joint pain by lumbar anaesthetic block. Exclusion criteria were lack of positive response to controlled comparative local anaesthetic blocks, uncontrollable or unstable opioid use, psychiatric disorders, pregnancy, and patients with a history or potential for adverse reaction(s) to local anaesthetic, Sarapin or steroid |
Interventions | Injection treatment (I): lumbar facet joint nerve blocks with local anaesthetic (bupivacaine 0.25%) (n = 60) Injection treatment (I2): lumbar facet joint nerve blocks with a mixture of bupivacaine and betamethasone (n = 60) |
Outcomes | There were no significant differences in treatment effect of (I) compared to (I2) at 3, 6, or 12 months post-treatment. Pain scores (mean ± SD) at baseline: (I) 8.2 ± 0.8, (I2) 7.9 ± 1.0; at 3 months (I) 3.8 ± 1.3, (I2) 3.5 ± 1.1; at 6 months (I) 3.6 ± 1.5, (I2) 3.3 ± 0.8; and at 12 months (I) 3.7 ± 1.7, (I2) 3.5 ± 1.1 |
Notes | There were no major adverse events reported over a period of 1 year Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded ?; co-interventions −; compliance +; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 8 |
Study: Marks 1992 |
Methods | RCT; “random number system” |
Participants | 86 patients with chronic LBP present most of the time for at least 6 months. Exclusion criteria were a radicular pattern in either lower limb, straight leg raising limited at <60°, and evidence of any progressive spinal disorder of non-degenerative origin |
Interventions | Injection treatment (I): lumbar facet joint injection with corticosteroids and anaesthetic (20 mg methylprednisolone acetate followed by 1.5 ml lignocaine) (n = 42) Injection treatment (I2): lumbar facet nerve block of the medial articular branch of the posterior primary ramus from L1 to L5 (20 mg methylprednisolone acetate followed by 1.5 ml lignocaine) (n = 44) |
Outcomes | (I) was slightly better in relieving pain than (I2). This difference reached statistical significance only at 1 month (P < 0.005) but not immediately after treatment, at 2 weeks, or at 3 months. 1 month post-treatment, 65.9% (n = 29) of (I2) reported no change in pain severity compared to 42.9% (n = 18) in (I) |
Notes | 5 subjects in each group had previous lumbar spine surgery No serious complications were reported. Transient symptoms, such as headache, paraesthesia of one leg, nausea and worsening of pain occurred 15 times in (I) and 18 times in (I2) Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded ?; outcomes blinded +; co-interventions −; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 8 |
Study: Mauro 2000 |
Methods | RCT; randomization procedure not described |
Participants | 60 patients, aged 18–65 years, with chronic LBP or sciatic neuritis of mechanical origin for at least 6 months, and a pain intensity of at least 60 mm on a VAS. Exclusion criteria included pregnancy, severe concurrent illnesses, and intolerance to paracetamol |
Interventions | Injection treatment (I): intramuscular injection (2 ml ampoules containing 1,000 mg vitamin B12) once daily for a 2-week period (n = 30) Reference treatment (R): sham intramuscular injection (2 ml placebo ampoules) once daily for a 2-week period (n = 30) |
Outcomes | At the end of the treatment period, pain VAS scores (mean ± SD) significantly decreased in (I) (75.53 ± 8.9 to 9.53 ± 16.5) compared with (R) (70.63 ± 7.9 to 36.83 ± 27.4) (P < 0.0001). Total scores on RDQ (mean ± SD) significantly declined more in (I) (from 13.27 ± 2.7 to 2.43 ± 2.6) than in (R) (from 11.53 ± 2.2 to 5.80 ± 3.3) (P < 0.0002). Mean consumption of paracetamol over the treatment period was higher in (R) compared to (I) (P < 0.01) |
Notes | No changes in vital signs or adverse effects were noted Methodological quality: randomization ?; treatment allocation ?; baseline similarity −; patients blinded ?; care providers blinded ?; outcomes blinded +; co-interventions ?; compliance +; drop outs −; timing of outcomes +; intention-to-treat −. Total score = 3 |
Study: Mayer 2004 |
Methods | RCT; assignment based on date of the month of their initial visit |
Participants | 70 patients with chronic disabling work-related lumbar spine disorders who had lumbar rigidity between 1 and 3 levels. Exclusion criteria included failure to achieve insurance pre-authorization and more than three levels of spinal rigidity |
Interventions | Injection treatment (I): lumbar facet joint injection on one to three levels bilaterally (1 ml 2% lidocaine, 1 ml 0.5% bupivacaine, and 1 ml of a depot corticosteroid preparation). In addition, a home stretching exercise program was instructed (n = 36) Reference treatment (R): home stretching exercise program (n = 34) |
Outcomes | No significant differences were found in pain and disability between the groups. The (I) group had a significantly greater improvement in range of motion at 5–7 weeks compared withh (R). Pain intensity (mean ± SD) improved from 6.3 ± 1.5 to 5.4 ± 1.6 in (I) and 6.7 ± 1.8 to 5.9 ± 2.1 in (R) |
Notes | 18 patients had a history of lumbar spinal surgery Adverse events were not reported by the study authors Methodological quality: randomization −; treatment allocation −; baseline similarity +; patients blinded −; care providers blinded −; outcomes blinded +; co-interventions ?; compliance ?; drop outs +; timing of outcomes ?; intention-to-treat ?. Total score = 3 |
Study: Nath 2008 |
Methods | RCT; “computer generated randomization schedule” |
Participants | 40 patients with chronic LBP of at least 2 years duration with 80% pain relief from two successive medial branch blocks. Excluded were patients with pregnancy, coagulopathies, malignancy, infections, mental handicap and psychiatric disorders; patients with a motor deficit or any other indication for surgical treatment |
Interventions | Injection treatment (I): radiofrequency denervation of lumbar facet joint for 60 s at 85°C (n = 20) Reference treatment (R): sham radiofrequency denervation of lumbar facet joint, same procedure as (I) but without application of current (n = 20) |
Outcomes | At baseline, (I) had significantly more generalised pain, low-back pain, hip ROM, and referred pain when compared with (R). 6 months post-treatment, on a 6-point global assessment scale, the (I) group had significantly more than the (R) group by 0.8 points (P < 0.004). Mean low-back pain VAS improved from 6.03 to 4.10 in (I) and from 4.35 to 3.98 in (R) (P = 0.02). In various secondary outcome measures, the (I) group exhibited improvements that were statistically and clinically greater than those in the (R) group |
Notes | Adverse events were not reported Methodological quality: randomization +; treatment allocation ?; baseline similarity −; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance ?; drop outs +; timing of outcomes +; intention-to-treat ?. Total score = 6 |
Study: Oh 2004 |
Methods | RCT; “randomly allocated” |
Participants | 49 patients with chronic discogenic LBP whose pain continued after undergoing intradiscal electrothermal annuloplasty (IDET) and who also had a positive diagnostic block of the ramus communicans nerve. Exclusion criteria were: spinal stenosis, spinal instability, multilevel (2 or more) disc lesions, previous spinal surgery, history of excessive bleeding or coagulopathy and obvious psychologic problems. Patients with a positive diagnostic block of the facet joints were also excluded |
Interventions | Injection treatment (I): radiofrequency thermocoagulation of the ramus communicans nerve (1% lidocaine was injected followed by RF thermocoagulation) at 65°C for 60 s (n = 26) Reference treatment (R): sham radiofrequency thermocoagulation, same procedure as (I), injection of 2 ml of preservative-free 1% lidocaine without RF thermocoagulation (n = 23) |
Outcomes | After 4 months, VAS pain scores were significantly lower in the (I) group than in the (R) group (P < 0.05). The scores of the (I) group were a mean of 11.3 points higher (P < 0.05) on the bodily pain subscale, and a mean of 12.4 points higher (P < 0.05) on the SF-36 physical function subscale, compared with the (R) group |
Notes | One patient in the (I) group complained of mild lower limb dysesthesia and weakness Methodological quality: randomization ?; treatment allocation −; baseline similarity +; patients blinded ?; care providers blinded −; outcomes blinded ?; co-interventions ?; compliance +; drop outs ?; timing of outcomes +; intention-to-treat ?. Total score = 3 |
Study: Pauza 2001 |
Methods | RCT; “computer-generated, random numbers” |
Participants | 64 patients aged 18–65 years with chronic LBP greater than leg pain and a posterior tear of the annulus fibrosus on provocation discography. Exclusion criteria were previous lumbar spine surgery; abnormal neurological examination; radicular pain; structural deformities; large or sequestered disc herniations; cervical or thoracic pain; uncontrolled or acute medical illnesses; rheumatoid arthritis; ambulatory dysfunction; pregnancy; workman’s compensation; injury litigation; disability remuneration; and allergy to contrast media or drugs to be used in the intended procedure Eight patients violated the protocol and were excluded from the final analysis |
Interventions | Injection treatment (I): intradiscal electrothermal therapy (IDET) to 90°C and a 12-week post-operative rehabilitation program (lumbar corset for 6 weeks, spine stabilization exercises for 6 weeks) (n = 32) Reference treatment (R): sham intradiscal electrothermal therapy, same procedure as above without application of current, and a 12-week post-operative rehabilitation program (n = 24) |
Outcomes | 6 months post-treatment, pain VAS scores (mean ± SD) in the (I) group decreased significantly more (6.6 ± 1.4 to 4.2 ± 2.6) than the (R) group (6.5 ± 1.9 to 5.4 ± 2.7) (P < 0.05). Oswestry disability scores (mean ± SD) decreased from 31 ± 10 to 20 ± 12 in (I) and from 33 ± 11 to 28 ± 15 in (R) (P = 0.05) |
Notes | No patient had any adverse effects attributable to their treatment Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded +; co-interventions +; compliance +; drop outs +; timing of outcomes +; intention-to-treat −. Total score = 9 |
Study: Revel 1998 |
Methods | RCT; randomisation method not stated |
Participants | 80 patients aged 18 years or more with chronic LBP unrelieved by analgesics, NSAIDs, and physical therapy. Exclusion criteria included previous back surgery, sciatica, sacroiliac joint pain, pregnancy, psychiatric disease and a history of adverse reaction to a lidocaine or corticosteroid injection |
Interventions | Injection treatment (I): lumbar facet joint injection with anaesthetic (1 ml 2% lidocaine) (n = 42) Reference treatment (R): lumbar facet joint injection with 1 ml saline (n = 38) Patients had 4–6 lower joints injected on both sides or 2–3 on the same side |
Outcomes | Post-treatment, pain relief was significantly better in the (I) group compared with the (R) group. In patients with fewer pain characteristics, pain (mean ± SD) decreased by −35.36 ± 23.6 in (I) compared to −11.87 ± 17.44 in (R) (P = 0.01) |
Notes | Adverse events were not reported Methodological quality: randomization ?; treatment allocation ?; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance ?; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 7 |
Study: Serrao 1992 |
Methods | RCT; “randomly allocated” |
Participants | 28 patients attending chronic LBP treatment. Patients with disc lesions and spinal claudication were excluded |
Interventions | Injection treatment (I): lumbar epidural injection with corticosteroid (80 mg prednisolone) plus 3 ml 5% dextrose injected into the intrathecal space (n = 14) Injection treatment (I2): lumbar epidural injection (10 ml normal saline) plus 2 mg midazolam dissolved in 3 ml 5% dextrose injected into the intrathecal space (n = 14) |
Outcomes | There were no significant differences between the groups post-treatment, or after 2 months follow-up for either pain intensity or unpleasantness. No significant differences were found between groups on psychological measures. Data in graphs |
Notes | Eight patients in the (I) group and seven in the (I2) group experienced headaches following treatment; nausea was experienced in two of the (I) patients and by one patient in the (R) group Methodological quality: randomization ?; treatment allocation ?; baseline similarity ?; patients blinded +; care providers blinded ?; outcomes blinded +; co-interventions −; compliance +; drop outs ?; timing of outcomes +; intention-to-treat ?. Total score = 4 |
Study: Tekin 2007 |
Methods | RCT; “random number generation” |
Participants | 60 patients, aged >17 years, with chronic LBP with or without radiating pain into the upper leg, focal tenderness over the facet joints and pain on hyperextension. Exclusion criteria were prior radiofrequency treatment, coagulation disturbances, allergies to contrast media or local anaesthetics, malignancy, psychiatric conditions and pregnancy. Only patients with a positive response (>50% pain relief for sufficient duration) to a diagnostic medial branch block were included |
Interventions | Injection treatment (I): radiofrequency denervation (conventional) medial branch lumbar nerve roots at 80°C for 90 s (n = 20) Injection treatment (I2): radiofrequency denervation (pulsed) medial branch lumbar nerve roots at 42°C for 240 s (n = 20) Reference treatment (R): sham radiofrequency denervation, similar procedure as (I), but only bupivacaine 0.5% 0.3 ml was injected (n = 20) |
Outcomes | Post-treatment VAS and ODI scores (mean ± SD) were lower in (I) (2.3 ± 1.4; 25.6 ± 6.5) and (I2) (2.8 ± 1.5; 24.4 ± 5.7) than in (R) (4.3 ± 1.0; 30.5 ± 5.7) (P < 0.001). At 6 months and 1 year follow-up, mean VAS score was similar in (R) and (I2) groups but lower in the (I) group compared with the others (P < 0.05). Mean ODI was lower in (I) and (I2) groups than (R) group at 1 year (P < 0.05) Patient satisfaction was lower in (R) than other groups (P = 0.03), and highest in (I) (P = 0.004) |
Notes | There were no complications related to the procedure during the follow-up period Methodological quality: randomization +; treatment allocation ?; baseline similarity +; patients blinded +; care providers blinded −; outcomes blinded ?; co-interventions +; compliance +; drop outs +; timing of outcomes +; intention-to-treat ?. Total score = 7 |
Study: van Alphen 1989 |
Methods | RCT; randomization method not stated |
Participants | 151 patients, aged 18–45 years, with proven disc herniation on myelography. 68 patients had symptoms for >6 months. Exclusion criteria were severe neurological deficits, previous lumbar disc surgery or chemonucleolysis, and pregnancy |
Interventions | Injection treatment (I): chemonucleolysis [2 ml (4,000 U) chymopapain injected into intervertebral disc] followed by physiotherapy (n = 34) Reference treatment (R): discectomy under general anaesthetic using an interlaminar approach followed by post-operative physiotherapy (n = 34) |
Outcomes | 12 months post-treatment, status of pain (disappeared, improved, unchanged, increased) = (I): n = 13, 14, 4, 0; (R): n = 16, 13, 5, 0 (not significant) |
Notes | Complications in both groups included increased neurological symptoms, dural defect with leakage of cerebrospinal fluid, and partial cauda equina in one patient Methodological quality: randomization +; treatment allocation −; baseline similarity ?; patients blinded −; care providers blinded −; outcomes blinded −; co-interventions ?; compliance −; drop outs −; timing of outcomes +; intention-to-treat −. Total score = 2 |
Study: van Kleef 1999 |
Methods | RCT; “[randomized] with help of a computer program” |
Participants | 31 patients, aged 20–60 years, with chronic LBP for >12 months and a positive diagnostic dorsal ramus nerve block. Patients with previous back surgery or known specific LBP were excluded. One patient refused follow-up and was excluded from the analysis |
Interventions | Injection treatment (I): radiofrequency denervation of lumbar facet joints (posterior primary ramus of the segmental nerves L3–L5) at 80°C for 60 s on one or both sides (n = 15) Reference treatment (R): sham radiofrequency denervation, electrodes introduced as in (I) but no radiofrequency current was applied (n = 16) |
Outcomes | After 8 weeks, the mean VAS ± SD for (R) and (I) was 4.8 ± 2.5 and 2.8 ± 2.4, respectively. This difference, and the difference in effect on the Oswestry disability scale and globally perceived effect were statistically significant. Three, 6, and 12 months after treatment there were significantly more “success” patients in the (I) group compared with (R) |
Notes | There were no complications during or after the interventions Methodological quality: randomization +; treatment allocation ?; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance +; drop outs ?; timing of outcomes +; intention-to-treat ?. Total score = 7 |
Study: van Wijk 2005 |
Methods | RCT; randomisation method not stated |
Participants | 81 patients, aged 17 years and over, with chronic LBP and a 50% pain VAS reduction on lumbar facet joint diagnostic block. Exclusion criteria were prior radiofrequency treatment, radicular syndrome, coagulopathies, specific allergies, cancer and pregnancy |
Interventions | Injection treatment (I): radiofrequency lumbar facet denervation (dorsal ramus medial branches) at 80°C for 60 s (n = 40) Reference treatment (R): sham radiofrequency denervation, same procedure as (I) but without applying radiofrequency current (n = 41) |
Outcomes | 3 months post-treatment, a combined outcome measure (VAS, physical activities, analgesic intake) showed no differences between (I) (success 27.5%) and (R) (success 29.3%) (P = 0.86). Globally perceived effect improved after (I) (P < 0.05). The other secondary outcome parameters showed no significant differences. Data in graphs |
Notes | 30% of patients reported treatment-related pain severe enough to necessitate analgesics. No differences were found between groups on the incidence of adverse events and complications Methodological quality: randomization +; treatment allocation +; baseline similarity +; patients blinded +; care providers blinded +; outcomes blinded +; co-interventions ?; compliance +; drop outs +; timing of outcomes +; intention-to-treat +. Total score = 10 |